GLUBIO THERAPEUTICS

GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.

#Financial #Website #More

GLUBIO THERAPEUTICS

Industry:

Biotechnology Health Care Medical

Founded:

2021-01-01

Address:

Hangzhou, Zhejiang, China

Country:

China

Website Url:

http://www.glubiotx.com

Status:

Active

Total Funding:

72 M USD

Investors List

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series A - GluBio Therapeutics

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series A - GluBio Therapeutics

gl-ventures_image

GL Ventures

GL Ventures investment in Series A - GluBio Therapeutics

e-fund-management-co-ltd_image

E Fund Management Co.,LTD.

E Fund Management Co.,LTD. investment in Series A - GluBio Therapeutics

k2-vc_image

K2VC

K2VC investment in Series A - GluBio Therapeutics

qiming-venture-partners_image

Qiming Venture Partners

Qiming Venture Partners investment in Series A - GluBio Therapeutics

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series A - GluBio Therapeutics

legend-capital_image

Legend Capital

Legend Capital investment in Series A - GluBio Therapeutics

Official Site Inspections

http://www.glubiotx.com

Host Informations
Whois Informations

Loading ...

More informations about "GluBio Therapeutics" on Search Engine